TY - JOUR
T1 - Potential of [11C]TMSX for the evaluation of adenosine A 2A receptors in the skeletal muscle by positron emission tomography
AU - Ishiwata, Kiichi
AU - Mizuno, Masaki
AU - Kimura, Yuichi
AU - Kawamura, Kazunori
AU - Oda, Keiichi
AU - Sasaki, Toru
AU - Nakamura, Yoshio
AU - Muraoka, Isao
AU - Ishii, Kenji
N1 - Funding Information:
This work was supported by the Grant-in-Aid for Scientific Research (B) No. 16390348 of the Japan Society for the Promotion of Science. The authors thank Ms. Miyoko Ando for her care of the subjects during PET measurement.
PY - 2004/10
Y1 - 2004/10
N2 - We examined the potential of [7-methyl-11C]-(E)-8-(3,4,5- trimethoxystyryl)-1,3,7-trimethylxanthine ([11C]TMSX) for the assessment of adenosine A2A receptors in muscle. In rodents, specific binding of [11C]TMSX was observed in muscle and heart by blockade with A2A-selective CSC and non-selective theophylline, but not with A1-selective DPCPX. Swimming exercise fluctuated radioligand-receptor binding in these tissues. In a PET study of two subjects, theophylline-infusion slightly deceased the distribution volume of [11C]TMSX in the heart (20% reduction) and muscle (10% reduction), which suggested the specific binding.
AB - We examined the potential of [7-methyl-11C]-(E)-8-(3,4,5- trimethoxystyryl)-1,3,7-trimethylxanthine ([11C]TMSX) for the assessment of adenosine A2A receptors in muscle. In rodents, specific binding of [11C]TMSX was observed in muscle and heart by blockade with A2A-selective CSC and non-selective theophylline, but not with A1-selective DPCPX. Swimming exercise fluctuated radioligand-receptor binding in these tissues. In a PET study of two subjects, theophylline-infusion slightly deceased the distribution volume of [11C]TMSX in the heart (20% reduction) and muscle (10% reduction), which suggested the specific binding.
KW - Adenosine A receptor
KW - Human
KW - Muscle
KW - Positron emission tomography
KW - [C]TMSX
UR - http://www.scopus.com/inward/record.url?scp=4644330956&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4644330956&partnerID=8YFLogxK
U2 - 10.1016/j.nucmedbio.2004.06.003
DO - 10.1016/j.nucmedbio.2004.06.003
M3 - Article
C2 - 15464397
AN - SCOPUS:4644330956
SN - 0969-8051
VL - 31
SP - 949
EP - 956
JO - Nuclear Medicine and Biology
JF - Nuclear Medicine and Biology
IS - 7
ER -